{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:47:39Z","timestamp":1786985259068,"version":"build-2736575974"},"reference-count":220,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005891","name":"National Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["H2020016"],"award-info":[{"award-number":["H2020016"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973840"],"award-info":[{"award-number":["81973840"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016350","name":"Sichuan Provincial Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2021XYCZ004"],"award-info":[{"award-number":["2021XYCZ004"]}],"id":[{"id":"10.13039\/501100016350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016350","name":"Sichuan Provincial Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2020ZD005"],"award-info":[{"award-number":["2020ZD005"]}],"id":[{"id":"10.13039\/501100016350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024YFFK0092"],"award-info":[{"award-number":["2024YFFK0092"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biopha.2026.119025","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T02:30:39Z","timestamp":1768962639000},"page":"119025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["RNA splicing dysregulation in hepatocellular carcinoma: Molecular mechanisms, therapeutic targets, and intervention strategies\u2014A comprehensive review"],"prefix":"10.1016","volume":"195","author":[{"given":"Shuai","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119025_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41575-024-01021-z","article-title":"Current and emerging strategies for the prevention of hepatocellular carcinoma","volume":"22","author":"Yeo","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41575-024-01024-w","article-title":"Precision models in hepatocellular carcinoma","volume":"22","author":"Barcena-Varela","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib3","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41575-024-00967-4","article-title":"Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions","volume":"21","author":"Mak","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","article-title":"Hepatocellular carcinoma: signaling pathways and therapeutic advances","volume":"10","author":"Zheng","year":"2025","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2026.119025_bib5","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s42255-024-00985-1","article-title":"From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research","volume":"6","author":"Hsu","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.biopha.2026.119025_bib7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/HEP.0000000000000479","article-title":"Cell metabolism-based therapy for liver fibrosis, repair, and hepatocellular carcinoma","volume":"81","author":"Gilgenkrantz","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119025_bib8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S2468-1253(24)00434-5","article-title":"Precision surgery for hepatocellular carcinoma","volume":"10","author":"Magyar","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S2468-1253(24)00247-4","article-title":"Combination locoregional and systemic therapies in hepatocellular carcinoma","volume":"10","author":"Zhong","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41575-025-01089-1","article-title":"Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma","volume":"22","author":"Lau","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2025.04.028","article-title":"Hepatocellular carcinoma in people living with HIV","volume":"83","author":"Fulgenzi","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-024-01734-2","article-title":"Alternative splicing and related RNA binding proteins in human health and disease","volume":"9","author":"Tao","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2026.119025_bib13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41580-022-00545-z","article-title":"The physiology of alternative splicing","volume":"24","author":"Marasco","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2026.119025_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41576-022-00556-8","article-title":"Regulation of pre-mRNA splicing: roles in physiology and disease, and therapeutic prospects","volume":"24","author":"Rogalska","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.biopha.2026.119025_bib15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41576-022-00514-4","article-title":"Alternative splicing as a source of phenotypic diversity","volume":"23","author":"Wright","year":"2022","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.biopha.2026.119025_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","article-title":"RNA splicing dysregulation and the hallmarks of cancer","volume":"23","author":"Bradley","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119025_bib17","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.molmed.2023.07.001","article-title":"Alternative splicing: a bridge connecting NAFLD and HCC","volume":"29","author":"Xu","year":"2023","journal-title":"Trends Mol. Med"},{"key":"10.1016\/j.biopha.2026.119025_bib18","article-title":"Perturbation of mRNA splicing in liver cancer: insights, opportunities and challenges","author":"Jia","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2026.119025_bib19","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1136\/gutjnl-2021-324554","article-title":"Alternative splicing of viral transcripts: the dark side of HBV","volume":"70","author":"Kremsdorf","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2026.119025_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41583-023-00717-6","article-title":"Alternative splicing in neurodegenerative disease and the promise of RNA therapies","volume":"24","author":"Nikom","year":"2023","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biopha.2026.119025_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2024.04.001","article-title":"Alternative splicing in EMT and TGF-\u03b2 signaling during cancer progression","volume":"101","author":"Zhang","year":"2024","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.biopha.2026.119025_bib22","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1016\/S0021-9258(18)81621-0","article-title":"Deregulation of alternative splicing of fibronectin pre-mRNA in malignant human liver tumors","volume":"264","author":"Oyama","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119025_bib23","first-page":"1653","article-title":"Splicing mutations of the p53 gene in human hepatocellular carcinoma","volume":"53","author":"Lai","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119025_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.1840190120","article-title":"Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinoma","volume":"19","author":"Hsu","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119025_bib25","first-page":"45","article-title":"Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas","volume":"61","author":"Musso","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119025_bib26","first-page":"127","article-title":"Differential alternative splicing expressions of telomerase reverse transcriptase in gastrointestinal cell lines","volume":"11","author":"Nagao","year":"2004","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2026.119025_bib27","doi-asserted-by":"crossref","first-page":"9194","DOI":"10.1158\/0008-5472.CAN-08-2600","article-title":"Role of a novel splice variant of mitotic arrest deficient 1 (MAD1), MAD1beta, in mitotic checkpoint control in liver cancer","volume":"68","author":"Sze","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2026.119025_bib28","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jhep.2010.04.038","article-title":"The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions","volume":"53","author":"Hanoun","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib29","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1172\/JCI74382","article-title":"Splicing regulator SLU7 is essential for maintaining liver homeostasis","volume":"124","author":"Elizalde","year":"2014","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2026.119025_bib30","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/0008-5472.CAN-15-1336","article-title":"DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression","volume":"76","author":"Borghesan","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2026.119025_bib31","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/hep.30235","article-title":"Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma","volume":"69","author":"Mantovani","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119025_bib32","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41467-020-14437-3","article-title":"MTR4 drives liver tumorigenesis by promoting cancer metabolic switch through alternative splicing","volume":"11","author":"Yu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119025_bib33","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jhep.2021.04.033","article-title":"Dysregulation of the ESRP2-NF2-YAP\/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease","volume":"75","author":"Hyun","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.canlet.2020.10.010","article-title":"Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma","volume":"496","author":"L\u00f3pez-C\u00e1novas","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119025_bib35","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/0008-5472.CAN-20-0948","article-title":"ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma Growth","volume":"82","author":"Ma","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2026.119025_bib36","article-title":"HBV Enhances Sorafenib Resistance in Hepatocellular Carcinoma by Reducing Ferroptosis via SRSF2-Mediated Abnormal PCLAF Splicing","volume":"24","author":"Liu","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119025_bib37","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1158\/0008-5472.CAN-24-1630","article-title":"Energy Stress-Induced circEPB41(2) Promotes Lipogenesis in Hepatocellular Carcinoma","volume":"85","author":"Yang","year":"2025","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2026.119025_bib38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s12964-024-01790-9","article-title":"ZMAT2 condensates regulate the alternative splicing of TRIM28 to reduce cellular ROS accumulation, thereby promoting the proliferation of HCC cells","volume":"22","author":"Zhu","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.biopha.2026.119025_bib39","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41576-025-00836-z","article-title":"The regulation and function of post-transcriptional RNA splicing","volume":"26","author":"Choquet","year":"2025","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.biopha.2026.119025_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13046-025-03279-w","article-title":"Targeting RNA splicing modulation: new perspectives for anticancer strategy?","volume":"44","author":"Lv","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119025_bib41","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.apsb.2025.03.023","article-title":"RNA splicing: Novel star in pulmonary diseases with a treatment perspective","volume":"15","author":"Niu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2026.119025_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104995","article-title":"Therapeutic potential of alternative splicing in cardiovascular diseases","volume":"101","author":"Cao","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2026.119025_bib43","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41569-022-00828-0","article-title":"Cardiac splicing as a diagnostic and therapeutic target","volume":"20","author":"Gotthardt","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2026.119025_bib44","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.aau0325","article-title":"Structures of the fully assembled Saccharomyces cerevisiae spliceosome before activation","volume":"360","author":"Bai","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119025_bib45","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1126\/science.8266094","article-title":"The U5 and U6 small nuclear RNAs as active site components of the spliceosome","volume":"262","author":"Sontheimer","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119025_bib46","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.aax3289","article-title":"Mechanism of 5\u2032 splice site transfer for human spliceosome activation","volume":"364","author":"Charenton","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119025_bib47","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2016.01.025","article-title":"Spliceosomal DEAH-Box ATPases Remodel Pre-mRNA to Activate Alternative Splice Sites","volume":"164","author":"Semlow","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119025_bib48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41580-024-00739-7","article-title":"Splicing regulation through biomolecular condensates and membraneless organelles","volume":"25","author":"Giudice","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2026.119025_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110069","article-title":"The emerging role of XBP1 in cancer","volume":"127","author":"Chen","year":"2020","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2026.119025_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9070791","article-title":"Roles of XBP1s in Transcriptional Regulation of Target Genes","volume":"9","author":"Park","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2026.119025_bib51","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/415092a","article-title":"IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA","volume":"415","author":"Calfon","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119025_bib52","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.kint.2023.06.016","article-title":"Beyond UPR: cell-specific roles of ER stress sensor IRE1\u03b1 in kidney ischemic injury and transplant rejection","volume":"104","author":"Qiu","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.biopha.2026.119025_bib53","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1038\/s41467-021-27597-7","article-title":"Decoding non-canonical mRNA decay by the endoplasmic-reticulum stress sensor IRE1\u03b1","volume":"12","author":"Le Thomas","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119025_bib54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/wrna.1260","article-title":"The RNAissance family: SR proteins as multifaceted regulators of gene expression","volume":"6","author":"Howard","year":"2015","journal-title":"Wiley Inter. Rev. RNA"},{"key":"10.1016\/j.biopha.2026.119025_bib55","article-title":"RNA splicing as a therapeutic target in cancer","author":"Lewis","year":"2025","journal-title":"Annu Rev. Pharm. Toxicol."},{"key":"10.1016\/j.biopha.2026.119025_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108887","article-title":"Alternative splicing in aging and aging-related diseases: From pathogenesis to therapy","volume":"272","author":"Han","year":"2025","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2026.119025_bib57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.canlet.2020.11.043","article-title":"Splicing factors: insights into their regulatory network in alternative splicing in cancer","volume":"501","author":"Du","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119025_bib58","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1016\/j.apsb.2023.05.022","article-title":"Towards understandings of serine\/arginine-rich splicing factors","volume":"13","author":"Li","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2026.119025_bib59","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1126\/science.adn8105","article-title":"Transcriptome-wide splicing network reveals specialized regulatory functions of the core spliceosome","volume":"386","author":"Rogalska","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119025_bib60","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-021-00486-7","article-title":"Alternative splicing and cancer: a systematic review","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2026.119025_bib61","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/gutjnl-2024-333127","article-title":"Perturbation of mRNA splicing in liver cancer: insights, opportunities and challenges","volume":"74","author":"Jia","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2026.119025_bib62","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2337\/dci24-0094","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association","volume":"48","author":"Cusi","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2026.119025_bib63","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","article-title":"Multiomics study of nonalcoholic fatty liver disease","volume":"54","author":"Sveinbjornsson","year":"2022","journal-title":"Nat. Genet"},{"key":"10.1016\/j.biopha.2026.119025_bib64","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.cmet.2021.09.008","article-title":"DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing","volume":"33","author":"Li","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2026.119025_bib65","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/hep.30350","article-title":"17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease","volume":"69","author":"Ma","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119025_bib66","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa1712191","article-title":"A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease","volume":"378","author":"Abul-Husn","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119025_bib67","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1093\/nar\/gkac165","article-title":"Dysregulated RNA polyadenylation contributes to metabolic impairment in non-alcoholic fatty liver disease","volume":"50","author":"Jobbins","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2026.119025_bib68","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1038\/s41467-023-42461-6","article-title":"Spliceosome component Usp39 contributes to hepatic lipid homeostasis through the regulation of autophagy","volume":"14","author":"Cui","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119025_bib69","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1038\/s41467-020-16918-x","article-title":"Hepatic HuR modulates lipid homeostasis in response to high-fat diet","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119025_bib70","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1038\/s41467-020-20028-z","article-title":"XBP1 links the 12-hour clock to NAFLD and regulation of membrane fluidity and lipid homeostasis","volume":"11","author":"Meng","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119025_bib71","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1080\/15548627.2020.1788889","article-title":"The unfolded protein response regulates hepatic autophagy by sXBP1-mediated activation of TFEB","volume":"17","author":"Zhang","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2026.119025_bib72","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.32708","article-title":"Hepatocyte leukotriene B4 receptor 1 promotes NAFLD development in obesity","volume":"78","author":"Liu","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119025_bib73","article-title":"Differences between hepatocellular carcinoma caused by alcohol and other aetiologies","author":"Ganne-Carri\u00e9","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib74","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1097\/HEP.0000000000000433","article-title":"Targeting hepatic serine-arginine protein kinase 2 ameliorates alcohol-associated liver disease by alternative splicing control of lipogenesis","volume":"78","author":"Li","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119025_bib75","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/hep4.1713","article-title":"Myeloid Endoplasmic Reticulum Resident Chaperone GP96 Facilitates Inflammation and Steatosis in Alcohol-Associated Liver Disease","volume":"5","author":"Ratna","year":"2021","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.biopha.2026.119025_bib76","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1124\/dmd.124.001873","article-title":"Correlations of Long Noncoding RNA HNF4A-AS1 Alternative Transcripts with Liver Diseases and Drug Metabolism","volume":"52","author":"Jin","year":"2024","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.biopha.2026.119025_bib77","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1172\/JCI132691","article-title":"Epithelial splicing regulatory protein 2-mediated alternative splicing reprograms hepatocytes in severe alcoholic hepatitis","volume":"130","author":"Hyun","year":"2020","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2026.119025_bib78","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2026.119025_bib79","article-title":"Activatable sulfur dioxide nanosonosensitizer enables precisely controllable sono-gaseous checkpoint trimodal therapy for orthotopic hepatocellular carcinoma","volume":"12","author":"Liang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2026.119025_bib80","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2026.119025_bib81","first-page":"265","article-title":"Preventing the progression of cirrhosis to decompensation and death","volume":"22","author":"Villanueva","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib82","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.cmet.2024.04.003","article-title":"TM7SF3 controls TEAD1 splicing to prevent MASH-induced liver fibrosis","volume":"36","author":"Isaac","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2026.119025_bib83","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13432","article-title":"Proangiogenic role of circRNA-007371 in liver fibrosis","volume":"56","author":"Zhao","year":"2023","journal-title":"Cell Prolif."},{"key":"10.1016\/j.biopha.2026.119025_bib84","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002738R","article-title":"Circular RNA circUbe2k promotes hepatic fibrosis via sponging miR-149-5p\/TGF-\u03b22 axis","volume":"35","author":"Zhu","year":"2021","journal-title":"Faseb J."},{"key":"10.1016\/j.biopha.2026.119025_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/cells12020215","article-title":"The Fibrotic Effects of LINC00663 in Human Hepatic Stellate LX-2 Cells and in Bile Duct-Ligated Cholestasis Mice Are Mediated through the Splicing Factor 2-Fibronectin","volume":"12","author":"Chu","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119025_bib86","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1096\/fj.201902438R","article-title":"Upregulation of KSRP by miR-27b attenuates schistosomiasis-induced hepatic fibrosis by targeting TGF-\u03b21","volume":"34","author":"Wang","year":"2020","journal-title":"Faseb J."},{"key":"10.1016\/j.biopha.2026.119025_bib87","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3350\/cmh.2022.0237","article-title":"Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis","volume":"29","author":"Lee","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110935","article-title":"Angiotensin II type-2 receptor attenuates liver fibrosis progression by suppressing IRE1\u03b1-XBP1 pathway","volume":"113","author":"An","year":"2024","journal-title":"Cell Signal"},{"key":"10.1016\/j.biopha.2026.119025_bib89","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.3350\/cmh.2024.0824","article-title":"Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment","volume":"31","author":"Hwang","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib90","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/hep.32241","article-title":"Risk of HBV reactivation during therapies for HCC: A systematic review","volume":"75","author":"Papatheodoridi","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119025_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2024.01.037","article-title":"Major HBV splice variant encoding a novel protein important for infection","author":"Chung","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib92","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2468-1253(24)00437-0","article-title":"Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: a systematic review and meta-analysis","volume":"10","author":"Liguori","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib93","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jhep.2021.02.009","article-title":"Translatomic profiling reveals novel self-restricting virus-host interactions during HBV infection","volume":"75","author":"Yuan","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib94","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2021.07.023","article-title":"A global survey of alternative splicing of HBV transcriptome using long-read sequencing","volume":"76","author":"Guan","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib95","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01345-23","article-title":"Intrahepatic homeobox protein MSX-1 is a novel host restriction factor of hepatitis B virus","volume":"98","author":"Shen","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2026.119025_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042211","article-title":"Multiomics Analysis of Endocytosis upon HBV Infection and Identification of SCAMP1 as a Novel Host Restriction Factor against HBV Replication","volume":"23","author":"Yousaf","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119025_bib97","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41571-024-00869-z","article-title":"FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions","volume":"21","author":"Katoh","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119025_bib98","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1038\/onc.2013.424","article-title":"Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing","volume":"33","author":"Lin","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119025_bib99","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","article-title":"Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment","volume":"13","author":"Stefan","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.biopha.2026.119025_bib100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jceh.2019.11.004","article-title":"Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology","volume":"10","author":"Doycheva","year":"2020","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib101","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/hep.29660","article-title":"Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies","volume":"67","author":"Simon","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119025_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.744512","article-title":"Diabetes mellitus increases the risk of hepatocellular carcinoma after direct-acting antiviral therapy: systematic review and meta-analysis","volume":"8","author":"V\u00e1ncsa","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.biopha.2026.119025_bib103","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2147\/CMAR.S188238","article-title":"Type 2 diabetes mellitus increases the risk of hepatocellular carcinoma in subjects with chronic hepatitis B virus infection: a meta-analysis and systematic review","volume":"11","author":"Tan","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.biopha.2026.119025_bib104","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/gutjnl-2013-305736","article-title":"The insulin-like growth factor 2 (IGF2) mRNA-binding protein p62\/IGF2BP2-2 as a promoter of NAFLD and HCC?","volume":"63","author":"Simon","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2026.119025_bib105","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/clinem\/dgab391","article-title":"Insulin-like Growth Factor 2 mRNA-Binding Protein 2-a Potential Link Between Type 2 Diabetes Mellitus and Cancer","volume":"106","author":"Cao","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2026.119025_bib106","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1158\/0008-5472.CAN-12-3824","article-title":"Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors","volume":"73","author":"Chettouh","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2026.119025_bib107","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13045-024-01549-2","article-title":"Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives","volume":"17","author":"Shen","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2026.119025_bib108","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jcmgh.2020.04.018","article-title":"Alternative Splicing in Hepatocellular Carcinoma","volume":"10","author":"Lee","year":"2020","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib109","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3350\/cmh.2018.0067","article-title":"Pathologic differential diagnosis of metastatic carcinoma in the liver","volume":"25","author":"Park","year":"2019","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib110","article-title":"HnRNPR-mediated UPF3B mRNA splicing drives hepatocellular carcinoma metastasis","author":"Wang","year":"2024","journal-title":"J. Adv. Res"},{"key":"10.1016\/j.biopha.2026.119025_bib111","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1158\/0008-5472.CAN-23-0544","article-title":"Super enhancer-regulated LncRNA LINC01089 induces alternative splicing of DIAPH3 to drive hepatocellular carcinoma metastasis","volume":"83","author":"Su","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2026.119025_bib112","article-title":"Cytoskeleton remodeling mediated by circRNA-YBX1 phase separation suppresses the metastasis of liver cancer","volume":"120","author":"Liu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119025_bib113","first-page":"1602","article-title":"Metabolic reprogramming and its clinical implication for liver cancer","volume":"78","author":"Yang","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119025_bib114","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13046-022-02302-8","article-title":"PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition","volume":"41","author":"Yang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2026.119025_bib115","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1158\/0008-5472.CAN-15-3373","article-title":"PAK4 Phosphorylates p53 at Serine 215 to Promote Liver Cancer Metastasis","volume":"76","author":"Xu","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2026.119025_bib116","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1002\/1878-0261.12826","article-title":"PDSS2-Del2, a new variant of PDSS2, promotes tumor cell metastasis and angiogenesis in hepatocellular carcinoma via activating NF-\u03baB","volume":"14","author":"Zeng","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.biopha.2026.119025_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102297","article-title":"NETosis in tumour microenvironment of liver: From primary to metastatic hepatic carcinoma","volume":"97","author":"Yang","year":"2024","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.biopha.2026.119025_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202305374","article-title":"Metabolic Enzyme SLC27A5 Regulates PIP4K2A pre-mRNA splicing as a noncanonical mechanism to suppress hepatocellular carcinoma metastasis","volume":"11","author":"Nie","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2026.119025_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216442","article-title":"Hypoxia-induced circ-CDYL-EEF1A2 transcriptional complex drives lung metastasis of cancer stem cells from hepatocellular carcinoma","volume":"578","author":"Kong","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119025_bib120","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41419-023-06293-y","article-title":"DNA methylation-activated full-length EMX1 facilitates metastasis through EMX1-EGFR-ERK axis in hepatocellular carcinoma","volume":"14","author":"Wen","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2026.119025_bib121","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s13046-022-02538-4","article-title":"A functional loop between YTH domain family protein YTHDF3 mediated m(6)A modification and phosphofructokinase PFKL in glycolysis of hepatocellular carcinoma","volume":"41","author":"Zhou","year":"2022","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2026.119025_bib122","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/hep.32195","article-title":"DDX17-regulated alternative splicing that produced an oncogenic isoform of PXN-AS1 to promote HCC metastasis","volume":"75","author":"Zhou","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119025_bib123","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1038\/s41388-021-01905-3","article-title":"LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing","volume":"40","author":"Lin","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119025_bib124","doi-asserted-by":"crossref","first-page":"8558","DOI":"10.7150\/thno.44873","article-title":"E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119025_bib125","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature06734","article-title":"The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth","volume":"452","author":"Christofk","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119025_bib126","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.tem.2025.03.009","article-title":"Targeting PKLR in liver diseases","volume":"36","author":"Yuan","year":"2025","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2026.119025_bib127","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.canlet.2020.11.018","article-title":"Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics","volume":"503","author":"Zhu","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119025_bib128","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.7150\/thno.42010","article-title":"Skipping of exon 10 in Axl pre-mRNA regulated by PTBP1 mediates invasion and metastasis process of liver cancer cells","volume":"10","author":"Shen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119025_bib129","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s13046-019-1417-3","article-title":"MEIS2C and MEIS2D promote tumor progression via Wnt\/\u03b2-catenin and hippo\/YAP signaling in hepatocellular carcinoma","volume":"38","author":"Guan","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2026.119025_bib130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hep.30147","article-title":"A coiled-coil domain containing 50 splice variant is modulated by serine\/arginine-rich splicing Factor 3 and promotes hepatocellular carcinoma in mice by the ras signaling pathway","volume":"69","author":"Wang","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119025_bib131","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1158\/0008-5472.CAN-15-3385","article-title":"Phenotypic and signaling consequences of a novel aberrantly spliced transcript FGF Receptor-3 in hepatocellular carcinoma","volume":"76","author":"Li","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2026.119025_bib132","doi-asserted-by":"crossref","first-page":"8457","DOI":"10.1038\/ncomms9457","article-title":"A splicing variant of Merlin promotes metastasis in hepatocellular carcinoma","volume":"6","author":"Luo","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119025_bib133","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.canlet.2013.04.030","article-title":"Cloning and characterization of a novel human BRMS1 transcript variant in hepatocellular carcinoma cells","volume":"337","author":"Wu","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119025_bib134","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/hep.26258","article-title":"MAT2B-GIT1 interplay activates MEK1\/ERK 1 and 2 to induce growth in human liver and colon cancer","volume":"57","author":"Peng","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119025_bib135","first-page":"887","article-title":"Expression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3","volume":"63","author":"Barbour","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119025_bib136","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119025_bib137","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/1097-0142(19920201)69:3<643::AID-CNCR2820690307>3.0.CO;2-0","article-title":"Nucleotide sequence of prothrombin gene in abnormal prothrombin-producing hepatocellular carcinoma cell lines","volume":"69","author":"Tagawa","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2026.119025_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101084","article-title":"Potential targets and therapeutics for cancer stem cell-based therapy against drug resistance in hepatocellular carcinoma","volume":"74","author":"Zhao","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.biopha.2026.119025_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116251","article-title":"DDX39B protects against sorafenib-induced ferroptosis by facilitating the splicing and cytoplasmic export of GPX4 pre-mRNA in hepatocellular carcinoma","volume":"225","author":"Li","year":"2024","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2026.119025_bib140","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.3892\/or.2015.3920","article-title":"RACK1 modulates apoptosis induced by sorafenib in HCC cells by interfering with the IRE1\/XBP1 axis","volume":"33","author":"Zhou","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2026.119025_bib141","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/hep.25834","article-title":"Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation","volume":"56","author":"Liu","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119025_bib142","first-page":"765","article-title":"MiR-374b re-sensitizes hepatocellular carcinoma cells to sorafenib therapy by antagonizing PKM2-mediated glycolysis pathway","volume":"9","author":"Zhang","year":"2019","journal-title":"Am. J. Cancer Res"},{"key":"10.1016\/j.biopha.2026.119025_bib143","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.3390\/cimb46050259","article-title":"Membrane Association of the Short Transglutaminase Type 2 Splice Variant (TG2-S) Modulates Cisplatin Resistance in a Human Hepatocellular Carcinoma (HepG2) Cell Line","volume":"46","author":"Meshram","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.biopha.2026.119025_bib144","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1074\/jbc.M111.291229","article-title":"DNA methylation-regulated miR-193a-3p dictates resistance of hepatocellular carcinoma to 5-fluorouracil via repression of SRSF2 expression","volume":"287","author":"Ma","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119025_bib145","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1158\/0008-5472.CAN-19-1117","article-title":"Transcriptionally active androgen receptor splice variants promote hepatocellular carcinoma progression","volume":"80","author":"Dauki","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119025_bib146","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-024-01124-2","article-title":"CD8+ T cell metabolic flexibility elicited by CD28-ARS2 axis-driven alternative splicing of PKM supports antitumor immunity","author":"Holling","year":"2024","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.biopha.2026.119025_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107713","article-title":"Alternative splicing: A key regulator in T cell response and cancer immunotherapy","volume":"215","author":"Yong","year":"2025","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2026.119025_bib148","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-024-01618-6","article-title":"NPM1 inhibits tumoral antigen presentation to promote immune evasion and tumor progression","volume":"17","author":"Wang","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2026.119025_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112877","article-title":"The splicing isoform Foxp3\u03942 differentially regulates tTreg and pTreg homeostasis","volume":"42","author":"Gu","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2026.119025_bib150","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jcmgh.2022.02.006","article-title":"Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular Carcinoma","volume":"13","author":"Zhu","year":"2022","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib151","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2026.119025_bib152","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12943-024-02199-1","article-title":"Deciphering a profiling based on multiple post-translational modifications functionally associated regulatory patterns and therapeutic opportunities in human hepatocellular carcinoma","volume":"23","author":"Lao","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2026.119025_bib153","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jhep.2024.04.010","article-title":"Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD","volume":"81","author":"Yang","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib154","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1101\/gad.278549.116","article-title":"Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma","volume":"30","author":"Dayton","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.biopha.2026.119025_bib155","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1038\/s41388-019-0764-z","article-title":"Sirtuin-mediated deacetylation of hnRNP A1 suppresses glycolysis and growth in hepatocellular carcinoma","volume":"38","author":"Yang","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119025_bib156","doi-asserted-by":"crossref","unstructured":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways 455 Nature2008, 10611068.","DOI":"10.1038\/nature07385"},{"key":"10.1016\/j.biopha.2026.119025_bib157","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/gutjnl-2013-305302","article-title":"PTEN antagonises Tcl1\/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis","volume":"63","author":"Hong","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2026.119025_bib158","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ncb3338","article-title":"A splicing switch from ketohexokinase-C to ketohexokinase-A drives hepatocellular carcinoma formation","volume":"18","author":"Li","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2026.119025_bib159","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00018-022-04504-x","article-title":"Unspliced XBP1 contributes to cholesterol biosynthesis and tumorigenesis by stabilizing SREBP2 in hepatocellular carcinoma","volume":"79","author":"Wei","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2026.119025_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111707","article-title":"circPRKAA1 activates a Ku80\/Ku70\/SREBP-1 axis driving de novo fatty acid synthesis in cancer cells","volume":"41","author":"Li","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2026.119025_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100141","article-title":"An integrated transcriptomics and proteomics analysis implicates lncRNA MALAT1 in the regulation of lipid metabolism","volume":"20","author":"Wang","year":"2021","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.biopha.2026.119025_bib162","first-page":"3106","article-title":"SUGP1 is a novel regulator of cholesterol metabolism","volume":"25","author":"Kim","year":"2016","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2026.119025_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102546","article-title":"HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma","volume":"58","author":"Yuan","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2026.119025_bib164","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1101\/gr.227181.117","article-title":"A human-specific switch of alternatively spliced AFMID isoforms contributes to TP53 mutations and tumor recurrence in hepatocellular carcinoma","volume":"28","author":"Lin","year":"2018","journal-title":"Genome Res"},{"key":"10.1016\/j.biopha.2026.119025_bib165","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1007006","article-title":"Melatonin inhibits HCC progression through regulating the alternative splicing of NEMO","volume":"13","author":"Bai","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2026.119025_bib166","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3350\/cmh.2021.0308","article-title":"Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma","volume":"28","author":"Sung","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119025_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107419","article-title":"Extracellular vesicles in the HCC microenvironment: Implications for therapy and biomarkers","volume":"209","author":"Cheng","year":"2024","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2026.119025_bib168","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40364-023-00492-7","article-title":"Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas","volume":"11","author":"Chang","year":"2023","journal-title":"Biomark. Res"},{"key":"10.1016\/j.biopha.2026.119025_bib169","doi-asserted-by":"crossref","DOI":"10.1080\/15592294.2023.2276371","article-title":"Alternative splicing of IRF3 plays an important role in the development of hepatocarcinoma","volume":"18","author":"Lv","year":"2023","journal-title":"Epigenetics"},{"key":"10.1016\/j.biopha.2026.119025_bib170","doi-asserted-by":"crossref","first-page":"13955","DOI":"10.1007\/s00432-023-05178-z","article-title":"Comprehensive analysis of CPSF4-related alternative splice genes in hepatocellular carcinoma","volume":"149","author":"Yuemaierabola","year":"2023","journal-title":"J. Cancer Res Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119025_bib171","first-page":"4906","article-title":"A spliceosome-associated gene signature aids in predicting prognosis and tumor microenvironment of hepatocellular carcinoma","volume":"15","author":"Wang","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.biopha.2026.119025_bib172","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s10020-021-00294-3","article-title":"Identification of prognostic alternative splicing events related to the immune microenvironment of hepatocellular carcinoma","volume":"27","author":"Yu","year":"2021","journal-title":"Mol. Med"},{"key":"10.1016\/j.biopha.2026.119025_bib173","article-title":"Integrating machine learning to construct aberrant alternative splicing event related classifiers to predict prognosis and immunotherapy response in patients with hepatocellular carcinoma","volume":"13","author":"Liu","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2026.119025_bib174","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/s41556-019-0409-z","article-title":"PTEN\u03b1 and PTEN\u03b2 promote carcinogenesis through WDR5 and H3K4 trimethylation","volume":"21","author":"Shen","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2026.119025_bib175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hep.20274","article-title":"S-adenosylmethionine and its metabolite induce apoptosis in HepG2 cells: Role of protein phosphatase 1 and Bcl-x(S)","volume":"40","author":"Yang","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119025_bib176","article-title":"Alternative splicing of EZH2 regulated by SNRPB mediates hepatocellular carcinoma progression via BMP2 signaling pathway","volume":"28","author":"Wang","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.biopha.2026.119025_bib177","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.ymthe.2025.02.032","article-title":"Antisense-mediated exon skipping targeting EZH2 suppresses tumor growth in a xenograft mouse model of hepatocellular carcinoma","volume":"33","author":"Bai","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2026.119025_bib178","doi-asserted-by":"crossref","first-page":"33147","DOI":"10.1074\/jbc.M805556200","article-title":"The biflavonoid isoginkgetin is a general inhibitor of Pre-mRNA splicing","volume":"283","author":"O'Brien","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119025_bib179","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1080\/15548627.2022.2119353","article-title":"Isoginkgetin, a potential CDK6 inhibitor, suppresses SLC2A1\/GLUT1 enhancer activity to induce AMPK-ULK1-mediated cytotoxic autophagy in hepatocellular carcinoma","volume":"19","author":"Yao","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2026.119025_bib180","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd3823","article-title":"The spliceosome as a target of novel antitumour drugs","volume":"11","author":"Bonnal","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2026.119025_bib181","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.2020004850","article-title":"SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS","volume":"136","author":"Malcovati","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2026.119025_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100728","article-title":"The role of alternative splicing in cancer: From oncogenesis to drug resistance","volume":"53","author":"Sciarrillo","year":"2020","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.biopha.2026.119025_bib183","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.tig.2017.03.001","article-title":"Splicing factor mutations in myelodysplasias: insights from spliceosome structures","volume":"33","author":"Jenkins","year":"2017","journal-title":"Trends Genet"},{"key":"10.1016\/j.biopha.2026.119025_bib184","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nchembio.2007.16","article-title":"Splicing factor SF3b as a target of the antitumor natural product pladienolide","volume":"3","author":"Kotake","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2026.119025_bib185","doi-asserted-by":"crossref","first-page":"9210","DOI":"10.1093\/nar\/gkae505","article-title":"MicroRNA biogenesis is broadly disrupted by inhibition of the splicing factor SF3B1","volume":"52","author":"Downie Ruiz Velasco","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2026.119025_bib186","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13073-018-0557-y","article-title":"Therapy-induced stress response is associated with downregulation of pre-mRNA splicing in cancer cells","volume":"10","author":"Anufrieva","year":"2018","journal-title":"Genome Med"},{"key":"10.1016\/j.biopha.2026.119025_bib187","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201847604","article-title":"U2AF(65) assemblies drive sequence-specific splice site recognition","volume":"20","author":"Tari","year":"2019","journal-title":"EMBO Rep."},{"key":"10.1016\/j.biopha.2026.119025_bib188","doi-asserted-by":"crossref","first-page":"17325","DOI":"10.1074\/jbc.M114.558825","article-title":"Cancer-relevant splicing factor CAPER\u03b1 engages the essential splicing factor SF3b155 in a specific ternary complex","volume":"289","author":"Loerch","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119025_bib189","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal3755","article-title":"Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15","volume":"356","author":"Han","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119025_bib190","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","article-title":"Arginine reprograms metabolism in liver cancer via RBM39","volume":"186","author":"Mossmann","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119025_bib191","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1101\/gad.219899.113","article-title":"Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery","volume":"27","author":"Bezzi","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.biopha.2026.119025_bib192","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ccell.2019.07.003","article-title":"Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation","volume":"36","author":"Fong","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2026.119025_bib193","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1002\/hep.31864","article-title":"Myelocytomatosis-Protein Arginine N-Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma","volume":"74","author":"Luo","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119025_bib194","article-title":"Intron Retention of DDX39A Driven by SNRPD2 is a Crucial Splicing Axis for Oncogenic MYC\/Spliceosome Program in Hepatocellular Carcinoma","author":"Chang","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.biopha.2026.119025_bib195","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1038\/s41598-019-39487-6","article-title":"A novel benzamine lead compound of histone deacetylase inhibitor ZINC24469384 can suppresses HepG2 cells proliferation by upregulating NR1H4","volume":"9","author":"Song","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119025_bib196","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/s41388-024-02988-4","article-title":"Targeting the IRE1\u03b1-XBP1s axis confers selective vulnerability in hepatocellular carcinoma with activated Wnt signaling","volume":"43","author":"Zhang","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119025_bib197","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/hep.24010","article-title":"Antihepatoma activity of chaetocin due to deregulated splicing of hypoxia-inducible factor 1\u03b1 pre-mRNA in mice and in vitro","volume":"53","author":"Lee","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119025_bib198","article-title":"Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells","volume":"6","author":"Chang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2026.119025_bib199","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1038\/s41598-017-07472-6","article-title":"4\u03b2-Hydroxywithanolide E Modulates Alternative Splicing of Apoptotic Genes in Human Hepatocellular Carcinoma Huh-7 Cells","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119025_bib200","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","article-title":"Antisense technology: an overview and prospectus","volume":"20","author":"Crooke","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2026.119025_bib201","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","article-title":"Antisense oligonucleotides: the next frontier for treatment of neurological disorders","volume":"14","author":"Rinaldi","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2026.119025_bib202","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jacc.2020.05.070","article-title":"Targeting RNA with antisense oligonucleotides and small interfering RNA: JACC state-of-the-art review","volume":"76","author":"Katzmann","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2026.119025_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108345","article-title":"PKM splice-switching ASOs induce upregulation of dual-specificity phosphatases and dephosphorylation of ERK1\/2 in hepatocellular carcinoma","volume":"301","author":"Voss","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119025_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2025.08.3757","article-title":"Phase 1b and Dose-Expansion Study of GSK3326595, a PRMT5 Inhibitor as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cancers","author":"Gounder","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2026.119025_bib205","article-title":"PRMT5 Inhibitor Synergizes with Chemotherapy to Induce Resembling Mismatch Repair Deficiency and Enhance Anti-TIGIT Therapy in Microsatellite-Stable Colorectal Cancer","volume":"12","author":"Zhu","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2026.119025_bib206","doi-asserted-by":"crossref","first-page":"9711","DOI":"10.1038\/s41598-018-28002-y","article-title":"Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing","volume":"8","author":"Gerhart","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119025_bib207","first-page":"6116","article-title":"Sulfonamide derivative, E7820, is a unique angiogenesis inhibitor suppressing an expression of integrin alpha2 subunit on endothelium","volume":"62","author":"Funahashi","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119025_bib208","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41698-024-00610-0","article-title":"A molecular glue RBM39-degrader induces synthetic lethality in cancer cells with homologous recombination repair deficiency","volume":"8","author":"Kohsaka","year":"2024","journal-title":"NPJ Precis Oncol."},{"key":"10.1016\/j.biopha.2026.119025_bib209","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/s41375-023-02050-4","article-title":"E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial","volume":"37","author":"Bewersdorf","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2026.119025_bib210","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.2217\/fon-2023-0872","article-title":"Preclinical and phase I studies of an antisense oligonucleotide drug targeting IGF-1R in liver cancer","volume":"20","author":"Li","year":"2024","journal-title":"Future Oncol."},{"key":"10.1016\/j.biopha.2026.119025_bib211","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1021\/acs.molpharmaceut.2c00026","article-title":"Activity and Tissue Distribution of Antisense Oligonucleotide CT102 Encapsulated with Cytidinyl\/Cationic Lipid against Hepatocellular Carcinoma","volume":"19","author":"Guan","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2026.119025_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111376","article-title":"SRSF10 facilitates HCC growth and metastasis by suppressing CD8(+)T cell infiltration and targeting SRSF10 enhances anti-PD-L1 therapy","volume":"127","author":"Luo","year":"2024","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.biopha.2026.119025_bib213","article-title":"Loss of ESRP2 Activates TAK1-MAPK Signaling through the Fetal RNA-Splicing Program to Promote Hepatocellular Carcinoma Progression","volume":"11","author":"Yan","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.biopha.2026.119025_bib214","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1186\/s12885-022-10174-6","article-title":"Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis","volume":"22","author":"Yang","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2026.119025_bib215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1261\/rna.080273.124","article-title":"Development of bioconjugate-based delivery systems for nucleic acids","volume":"31","author":"Wahane","year":"2024","journal-title":"Rna"},{"key":"10.1016\/j.biopha.2026.119025_bib216","article-title":"Integrating single cell analysis and machine learning methods reveals stem cell-related gene S100A10 as an important target for prediction of liver cancer diagnosis and immunotherapy","volume":"15","author":"Huang","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2026.119025_bib217","article-title":"Determining the Prognostic Value of Spliceosome-Related Genes in Hepatocellular Carcinoma Patients","volume":"9","author":"Liu","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biopha.2026.119025_bib218","first-page":"1929","article-title":"Identification and validation of alternative splicing isoforms as novel biomarker candidates in hepatocellular carcinoma","volume":"41","author":"Wu","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2026.119025_bib219","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1038\/s41467-022-34299-1","article-title":"Phosphorylation of 17\u03b2-hydroxysteroid dehydrogenase 13 at serine 33 attenuates nonalcoholic fatty liver disease in mice","volume":"13","author":"Su","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119025_bib220","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jare.2024.02.010","article-title":"HnRNPR-mediated UPF3B mRNA splicing drives hepatocellular carcinoma metastasis","volume":"68","author":"Wang","year":"2025","journal-title":"J. Adv. Res."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:39:08Z","timestamp":1778693948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226000570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":220,"alternative-id":["S0753332226000570"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119025","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNA splicing dysregulation in hepatocellular carcinoma: Molecular mechanisms, therapeutic targets, and intervention strategies\u2014A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119025"}}